Mounjaro launches in India, fueled by celebrity endorsements

Eli Lilly's weight-loss drug Mounjaro has launched in India, sparking discussions about celebrity endorsements of medical weight loss. Following the success of similar drugs like Ozempic and Wegovy, Mounjaro is gaining attention as a treatment for obesity. Celebrities such as Oprah Winfrey and Karan Johar are often linked to these drugs, fueling speculation among their fans. Oprah Winfrey has been open about her weight struggles and confirmed in a recent interview that she uses a weight-loss medication. She expressed that having a medical option for weight management feels like a gift. Other stars, including Kelly Clarkson, Kathy Bates, and Amy Schumer, have shared their experiences with weight-loss medications, highlighting the importance of honesty in discussing their journeys. Comedian Jim Gaffigan spoke about his significant weight loss with Mounjaro, stating it has improved his quality of life. Other celebrities, such as Whoopi Goldberg and Sharon Osbourne, have also shared their experiences with these medications, ranging from positive results to side effects. As Mounjaro becomes available in India, the local wellness scene is expected to change. The medical community warns that these drugs should not be seen as quick fixes. They emphasize that Mounjaro and similar medications are prescription treatments for chronic conditions, not beauty enhancements. With more celebrities opening up about their use of weight-loss drugs, the stigma around them may lessen, but medical guidance remains essential.